Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Strains and reagents

JX Jinglin L. Xie
LQ Longguang Qin
ZM Zhengqiang Miao
BG Ben T. Grys
JD Jacinto De La Cruz Diaz
KT Kenneth Ting
JK Jonathan R. Krieger
JT Jiefei Tong
KT Kaeling Tan
ML Michelle D. Leach
TK Troy Ketela
MM Michael F. Moran
DK Damian J. Krysan
CB Charles Boone
BA Brenda J. Andrews
AS Anna Selmecki
KW Koon Ho Wong
NR Nicole Robbins
LC Leah E. Cowen
request Request a Protocol
ask Ask a question
Favorite

All C. albicans strains were archived in 25% glycerol and stored at −80 °C. Strains were grown in YPD (1% yeast extract, 2% bactopeptone, and 2% glucose) at 30 °C unless otherwise specified. For solid media, 2% agar was added. Strains were constructed according to standard protocols. Strains used in this study are listed in Supplementary Table 1. Caspofungin was generously provided by Terry Roemer (Department of Infectious Diseases, Merck Research Laboratories) and was diluted to a 100 µg/ml stock, and used at a final concentration of 125 ng/ml. Doxycycline (DOX, BD Biosciences #631311) was formulated in a 20 mg/ml stock in water and used at a final concentration of 0.02 µg/ml or 1 µg/ml, as specified.

Copyright and License information: The Author(s) ©2017
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A